Octagon Capital Advisors »

Perspective Therapeutics shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by Octagon Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $16M 1.6M 9.97

More positions owned by Octagon Capital Advisors

Apellis Pharmaceuticals Call Option (APLS)
Insmed Com Par $.01 Call Option (INSM)
Dianthus Therapeutics (DNTH)
Structure Therapeutics Sponsored Ads (GPCR)
Dyne Therapeutics (DYN)
Arrivent Biopharma (AVBP)
Verona Pharma Sponsored Ads (VRNA)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Bridgebio Pharma (BBIO)
Ocular Therapeutix (OCUL)
Perspective Therapeutics Com New (CATX)
Mind Medicine Mindmed Com New (MNMD)
Praxis Precision Medicines I Com New (PRAX)
Taysha Gene Therapies Com Shs (TSHA)

View all positions for Octagon Capital Advisors

Top funds holding Perspective Therapeutics

Commodore Capital
Henderson Group
BlackRock
Avidity Partners Management
Vanguard Group
Deerfield Management Company
Nicholson Wealth Management Group
Octagon Capital Advisors
Marshall Wace
Geode Capital Management
Hills Bank And Trust Company
State Street Corporation
Ghost Tree Capital
Paradigm Biocapital Advisors
Sphera Funds Management

View all funds holding Perspective Therapeutics